Acne does not end with the breakout. A global prevalence study by Tan & Bhate (2015) in the British Journal of Dermatology found that more than 50% of adults who have experienced inflammatory acne develop persistent post-inflammatory erythema (PIE — red/pink flat marks) or atrophic scarring (boxcar, ice-pick, or rolling craters). These sequelae can outlast the active acne by decades if left unaddressed, because the remodelling of damaged dermal collagen is a slow, under-resourced process in adult skin. Near-infrared (NIR) LED photobiomodulation at 660–850 nm addresses two of the three core mechanisms driving persistent acne scarring: the residual microvascular dysregulation responsible for PIE, and the suboptimal fibroblast collagen synthesis rate that prevents atrophic scars from filling in. This guide explains the science in detail and provides a practical at-home NIR protocol for adults managing post-acne skin wellness.
Types of Adult Acne Scars
Types of Adult Acne Scars
Acne scarring in adults encompasses a broader phenotypic range than in adolescents, partly because adult skin has lower basal collagen synthesis rates and slower wound healing. The main categories:
- Post-inflammatory erythema (PIE): Flat, pink-to-red marks resulting from dilated capillaries and damaged vascular architecture in the healing dermis. PIE is technically not a scar but a vascular response; it typically resolves within 3–6 months in healthy young adults but may persist for 12–24 months in adults with impaired microvascular regeneration or active sun exposure.
- Post-inflammatory hyperpigmentation (PIH): Brown/tan flat marks from melanocyte hyperstimulation during the healing process. More common in Fitzpatrick skin types III–VI. NIR at 660 nm has limited direct effect on melanin but may indirectly help by reducing the inflammatory trigger for continued melanin production.
- Atrophic scars (three subtypes):
- Ice-pick: Deep (2–4 mm), narrow (<2 mm) channels extending into the deep dermis or subcutis. The most difficult to address with surface treatments.
- Boxcar: Wider (3–5 mm), flat-bottomed depressions with sharply defined vertical walls. Depth varies 0.1–0.5 mm. Most responsive to surface photobiomodulation approaches.
- Rolling: Broad (4–6 mm), shallow depressions with sloping edges caused by fibrous adhesions between the dermis and subcutis. NIR may support the fibrolytic and collagen-remodelling processes that influence these adhesions.
- Hypertrophic scars: Raised, erythematous scars remaining within the original wound boundary. Relatively uncommon in facial acne; more common in chest and back acne. Approach with care — overstimulation with high fluence may not benefit raised scars.
Pathophysiology of Scar Formation
Pathophysiology of Scar Formation
Acne scar formation results from disrupted wound healing at the follicular level following a comedonal or inflammatory acne lesion. The normal wound-healing cascade proceeds through haemostasis → inflammation → proliferation → remodelling. In acne scars, the remodelling phase — which can last 12–24 months in healthy skin — is characterised by inadequate collagen deposition relative to the tissue deficit created by the inflammatory necrosis of the pilosebaceous unit.
Key pathomechanisms relevant to NIR intervention:
| Mechanism | Consequence | NIR Countermeasure | Expected Timeline |
|---|---|---|---|
| Capillary dropout / dilated tortuous capillaries (PIE) | Persistent erythema; poor nutrient delivery to repair fibroblasts | NO-mediated microvascular normalisation; reduced endothelin-1 | 4–8 weeks for visible PIE reduction |
| Fibroblast senescence in scar zone | Reduced collagen I/III synthesis; scar does not fill in | ATP increase reactivates fibroblast metabolism; TGF-β1 upregulation | 8–16 weeks for measurable collagen increase |
| Elevated MMP-1 / MMP-3 in scar tissue | Ongoing collagen degradation exceeds synthesis | NIR NF-κB suppression reduces MMP expression | 4–12 weeks for MMP normalisation |
| Hypoxic dermal microenvironment | Suppresses HIF-1α-driven VEGF for capillary regrowth | NIR O₂ enhancement via improved circulation restores normoxia | 2–6 weeks to improve local oxygenation |
How NIR LED Supports Scar Tissue Remodelling
How NIR LED Supports Scar Tissue Remodelling
NIR photobiomodulation interacts with scar tissue through three primary pathways that together support the biological conditions needed for improved remodelling:
1. Mitochondrial ATP Generation in Scar-Zone Fibroblasts
Fibroblasts in mature scar tissue are metabolically compromised — the dense, disorganised collagen of the scar matrix impedes their migration and reduces oxygen tension in the scar centre. NIR at 850 nm drives CcO activation even in hypoxic conditions (photodissociation of NO from CcO does not require atmospheric oxygen), restoring mitochondrial function and ATP synthesis. Avci et al. (2013) demonstrated that 660 nm irradiation at 3 J/cm² increased procollagen type I C-peptide (PICP) production in human dermal fibroblasts by 151% in culture — a finding replicated across multiple cell studies using similar fluence parameters.
2. Vascular Remodelling for PIE
PIE results from residual dilated, tortuous capillaries in the post-acne dermis — vessels that failed to fully regress after the inflammatory episode. NIR-driven NO production has a normalising effect on vascular architecture: controlled NO signalling promotes physiological vessel remodelling (via VEGF and angiopoietin pathways) rather than the abnormal vessel maintenance seen in PIE. In practice, clinicians using 660 nm LED at 3–6 J/cm² on PIE lesions report visible colour improvement at 6–8 weeks, consistent with capillary normalisation.
3. Anti-Inflammatory Microenvironment
Residual low-grade inflammation around atrophic scars — driven by persistent bacterial lipopolysaccharide remnants in the pilosebaceous follicle and ongoing oxidative stress from UV exposure — maintains elevated MMP-1 expression that continues to degrade newly synthesised collagen as fast as fibroblasts can produce it. NIR suppression of NF-κB nuclear translocation reduces MMP-1 transcription, shifting the balance toward net collagen deposition. This mechanism is particularly important for adults over 35, whose baseline inflammatory cytokine levels (notably IL-6) are higher than in adolescents, sustaining the post-acne inflammatory loop.
Wavelength Comparison for Scar Care
Wavelength Comparison for Scar Care
Different wavelengths penetrate to different skin depths and activate distinct cellular targets. For adult acne scar care, understanding this distinction guides protocol selection:
| Wavelength | Penetration Depth | Primary Target | Best Application for Acne Scars |
|---|---|---|---|
| 630–660 nm (visible red) | 1–3 mm (epidermis + upper dermis) | Superficial fibroblasts, capillary endothelium | PIE reduction; superficial boxcar scars; overall collagen density improvement |
| 810–850 nm (NIR) | 3–5 mm (deep dermis + subcutis) | Deeper fibroblasts, subdermal vasculature, adipose | Rolling scars with dermal-subcutaneous adhesions; deep boxcar base stimulation |
| Combined 660 nm + 850 nm | Full dermis | All dermal layers | Comprehensive maintenance protocol; maximum collagen synthesis response |
de Freitas & Hamblin (2016) demonstrated that the combined 660 nm + 850 nm protocol produced a 1.5–2× greater fibroblast proliferation response than either wavelength used alone at equivalent total fluence, supporting a dual-wavelength approach for comprehensive scar remodelling support.
NIR Protocol for Acne Scar Wellness
NIR Protocol for Acne Scar Wellness
Pre-Treatment Preparation
- Cleanse face with a gentle, pH-balanced cleanser (pH 4.5–5.5). Pat dry thoroughly — wet skin increases reflectance and reduces effective photon delivery.
- Do not apply retinol, AHA/BHA, or vitamin C serums before the session. These can interact with the photon environment. Apply post-session instead.
- If treating the face, wear provided goggles or keep eyes gently closed throughout.
- Ensure the room is cool (20–22 °C) — warm environments cause vasoconstriction-preventing vasodilation that may reduce the additive circulatory effect of NIR.
Phase-Based Protocol
| Phase | Wavelength | Fluence | Duration | Frequency |
|---|---|---|---|---|
| Phase 1: PIE (weeks 1–8) | 660 nm | 3–5 J/cm² | 6–8 min full face | 5×/week |
| Phase 2: Atrophic scars (weeks 1–16) | 850 nm | 5–8 J/cm² | 8–10 min scar zones | 4–5×/week |
| Phase 3: Combined maintenance (month 4+) | 660 nm + 850 nm | 5–7 J/cm² | 8–10 min full face | 3–4×/week |
Zone-Specific Focus
For ice-pick scars: apply 850 nm for 2 minutes specifically over the scar concentration zone (typically cheeks and temples) in addition to the full-face sweep. The deeper penetration of 850 nm is needed to reach the scar base. For rolling scars: combine 850 nm over the scar zone with gentle upward facial massage post-session to mechanically promote fibroblast migration to the scar-adipose adhesion site.
Complementary Skincare Integration
Complementary Skincare Integration
NIR photobiomodulation is most powerful when integrated into a broader scar-wellness skincare programme. Post-session is an optimal window for active ingredient application, as NIR-driven microcirculation enhancement may improve transdermal penetration of topical actives.
- Vitamin C serum (L-ascorbic acid, 10–15%): Vitamin C is an obligate cofactor for prolyl and lysyl hydroxylase — the enzymes that stabilise collagen triple helices. Applying immediately post-NIR capitalises on upregulated TGF-β1 signalling to produce higher-quality collagen. Use a stabilised form (sodium ascorbyl phosphate, ascorbyl glucoside) if L-ascorbic acid irritates post-NIR skin.
- Niacinamide (5%): Niacinamide reduces melanin transfer from melanocytes to keratinocytes, addressing PIH. It also strengthens the skin barrier, reducing transepidermal water loss in scar tissue where barrier function is typically impaired. It is compatible with post-NIR application.
- Centella asiatica extract: Asiaticoside and madecassic acid stimulate TGF-β1 independently, acting synergistically with NIR-driven TGF-β1 upregulation for collagen support. Increasingly included in science-backed scar serums.
- Retinol (0.025–0.05%): Use on alternate nights to the NIR session if possible, as retinol increases photosensitivity. Retinol drives fibroblast collagen production and speeds epidermal turnover, complementing NIR at the tissue level. Do not apply retinol immediately before or after NIR.
- Daily SPF 30–50: UV exposure upregulates MMP-1, directly counteracting NIR-stimulated collagen synthesis. Consistent daily SPF is non-negotiable in any evidence-based scar management programme.
Safety and Precautions
Safety and Precautions
- Active acne lesions: Avoid applying NIR directly over active inflamed acne pustules or cysts. 660 nm has some anti-bacterial effect on C. acnes via porphyrin photoactivation, but 850 nm at high fluence may theoretically increase local perfusion to active lesions. Focus NIR on post-acne scar areas that are clear of active lesions.
- Eye protection: Mandatory during facial application. Use the goggles provided with the device or close the eyes when the device passes near the orbital area. 660 nm and 850 nm cannot be seen and will not trigger the blink reflex at subthreshold intensities.
- Hyperpigmentation (PIH) caution: For users with Fitzpatrick types IV–VI and prominent PIH, start with lower fluence (2–3 J/cm² at 660 nm) and assess for post-inflammatory darkening after 2 weeks before increasing. In darker skin types, the photobiological response in melanocytes at higher fluence is less well-characterised.
- Retinoid users: Do not apply retinol or prescription retinoids on the same day as the NIR session. Retinoids dramatically increase photosensitivity and can cause erythema and barrier disruption when combined with photon irradiation on the same day.
- Isotretinoin (oral Roaccutane) users: Consult your dermatologist before starting NIR routines during or within 6 months of oral isotretinoin treatment, as skin is in a state of significantly altered photosensitivity and barrier function during this period.
- CIRIUS is a healthcare/wellness device and is not intended to diagnose, treat, cure, or prevent any disease. This protocol supports skin wellness; for active acne treatment, consult a dermatologist.
